⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

COO

The Cooper Companies, Inc.

Healthcare · Medical Instruments & Supplies

63.48USD

-4.2100 (-6.22%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗

Estimates and surprises

Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.

PeriodConsensus EPS90 days agoRevisions up (30d)Revisions down (30d)
Current quarter$1.12▼$1.1901
Next quarter$1.19▼$1.2301
Current year$4.63▲$4.6201
Next year$5▼$5.0201

Recent quarters

Beat in 4 of the last 4

QuarterEstimateActualSurprise
2026-04-30$1.09$1.21+0.12 (+10.5%)
2026-01-31$1.03$1.1+0.07 (+7.1%)
2025-10-31$1.11$1.15+0.04 (+3.3%)
2025-07-31$1.07$1.1+0.03 (+3.0%)

Wall Street coverage

57 ratings from 13 firms

Ratings are attributed to the research firm, not to individual analysts. See every ticker.

FirmActionRatingPrice TargetDate
CitigroupMaintainedNeutral$76 $80Aug 13, 2026
UBSInitiatedNeutral$75Jul 28, 2026
CitigroupMaintainedNeutral$69 $76Jul 8, 2026
BNP ParibasMaintainedOutperform$95 $92Jun 8, 2026
JP MorganMaintainedNeutral$80 $71Jun 5, 2026
StifelMaintainedBuy$95 $85Jun 5, 2026
Wells FargoMaintainedEqual-Weight$82 $66Jun 5, 2026
NeedhamMaintainedBuy$101 $86Jun 5, 2026
BairdMaintainedOutperform$98 $85Jun 5, 2026
MizuhoMaintainedOutperform$100 $85Jun 4, 2026
Piper SandlerReiteratedOverweight$94 $86Jun 1, 2026
CitigroupMaintainedNeutral$80 $69May 28, 2026
CitigroupMaintainedNeutral$88 $87Mar 6, 2026
BarclaysMaintainedOverweight$98 $103Mar 6, 2026
NeedhamMaintainedBuy$99 $101Mar 6, 2026
NeedhamMaintainedBuy$100 $99Feb 3, 2026
BarclaysMaintainedOverweight$97 $98Jan 26, 2026
CitigroupMaintainedNeutral$72 $88Dec 8, 2025
Morgan StanleyMaintainedEqual-Weight$76 $83Dec 8, 2025
Goldman SachsMaintainedSell$64 $71Dec 8, 2025
StifelReiteratedBuy$85 $95Dec 5, 2025
Piper SandlerReiteratedOverweight$83 $94Dec 5, 2025
Wells FargoMaintainedEqual-Weight$72 $82Dec 5, 2025
JP MorganMaintainedNeutral$66 $78Dec 5, 2025
MizuhoMaintainedOutperform$85 $100Dec 5, 2025

Insider transactions

51 filings from 16 insiders · 0 buy / 0 sell over 6m

Officers and directors of COO, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.

InsiderActionSharesPriceValueDate
LUCCHESE CYNTHIA LDirectorOther3.3k——Apr 1, 2026
MADDEN TERESA SMITHDirectorOther3.3k——Apr 1, 2026
WEISS ROBERT SDirectorOther3.7k——Apr 1, 2026
ROSEBROUGH WALTER M JRDirectorOther832——Apr 1, 2026
RIVAS MARIADirectorOther3.3k——Apr 1, 2026
CARBONE BARBARADirectorOther3.0k——Apr 1, 2026
KURZIUS LAWRENCE ERIKDirectorOther3.3k——Apr 1, 2026
JAY COLLEEN EDirectorOther3.3k——Apr 1, 2026
JAY COLLEEN EDirectorExercise7.1k$39.40$278kJan 12, 2026
MCBRIDE DANIEL GChief Operating OfficerOther12.9k——Jan 8, 2026
ANDREWS BRIAN GChief Financial OfficerOther3.5k——Jan 8, 2026
SHEFFIELD HOLLY ROfficerOther8.1k——Jan 8, 2026
WARNER GERARD H, IIIOfficerOther11.5k——Jan 8, 2026
WHITE ALBERT G IIIChief Executive OfficerOther18.3k——Jan 8, 2026
LUCCHESE CYNTHIA LDirectorBuy1.8k$84.06$150kDec 22, 2025
RIVAS MARIADirectorBuyindirect1.0k$82.13$82kDec 18, 2025
KURZIUS LAWRENCE ERIKDirectorBuy2.0k$82.50$165kDec 17, 2025
WHITE ALBERT G IIIChief Executive OfficerBuy10.0k$80.80$808kDec 16, 2025
SHEFFIELD HOLLY ROfficerBuy1.2k$80.75$99kDec 16, 2025
WEISS ROBERT SDirectorGiftindirect7.5k——Dec 12, 2025

Analyst Notes

Sign in to write

No analyst notes on COO yet.

Analyst Ratings

14 analysts covering

PeriodStrong BuyBuyHoldSellStrong SellConsensus
Current46600Buy2.13
1 mo ago46600Buy2.13
2 mo ago46510Buy2.19
Price target$81.50$66.00 – $92.00
+28.4% to target